Healthcare Services Group (HCSG) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 revenue was $426.3 million, up 1.8% year-over-year, driven by Dietary segment growth and stable Housekeeping revenues, matching expectations.
Net loss was $1.8 million (diluted EPS of $(0.02)), compared to net income of $8.3 million in Q2 2023, primarily due to $0.22 per share in client restructuring charges and a significant increase in bad debt provision from LaVie Care Centers' bankruptcy.
Cash flow from operations was $16.3 million, with adjusted cash flow used in operations at $2.4 million; over 96% cash collections achieved, showing year-over-year improvement.
The company reaffirmed its 2024 adjusted cash flow target of $40–$55 million, expecting to recover $12–$15 million in delayed collections related to the Change Healthcare cyberattack in H2.
Industry fundamentals are improving, with workforce availability rising, occupancy at 79.3% (near pre-pandemic levels), and a stable reimbursement environment, though inflation and labor shortages persist.
Financial highlights
Housekeeping and Laundry segment revenue was $191 million with an 8.9% margin; Dining and Nutrition segment revenue was $235.3 million with a 6.3%–6.4% margin.
Cost of services was $384.7 million (90.2%–90.3% of revenue), including $21.9 million in client restructuring bad debt and $9.8 million in aging-related bad debt.
SG&A was $44.4 million (10.4% of revenue), with a goal to reduce this to 8.5%–9.5% as revenue grows.
Adjusted EBITDA was $4.0 million (0.9% of revenue), down from $17.4 million (4.2%) in Q2 2023; methodology now excludes bad debt and self-insurance actuarial adjustments.
DSO for the quarter was 85 days; current ratio at quarter-end was 2.7.
Outlook and guidance
Q3 and Q4 2024 revenue estimates raised to $425–$435 million and $430–$440 million, respectively.
2024 adjusted cash flow forecast reaffirmed at $40–$55 million, with expectations to recover delayed collections in H2.
Management expects continued pressure from inflation and labor costs, with ongoing efforts to pass through cost increases and maintain cost controls.
The company believes cash from operations, existing cash, and credit lines will be adequate for foreseeable needs, but notes risks from customer payment delays and reimbursement changes.
Long-term, the company anticipates mid-single digit top-line growth over the next 3–5 years.
Latest events from Healthcare Services Group
- Q2 revenue reached $470.8M with margin gains, strong cash flow, and active share repurchases.HCSG
Q2 2026 - Dominates outsourced healthcare services with strong growth, financials, and client retention.HCSG
Investor presentation - Q1 2026 saw 3.4% revenue growth, 51% higher net income, and robust share repurchases.HCSG
Q1 2026 - Shareholders to vote on directors, pay, auditor, and equity plan amid strong growth and governance.HCSG
Proxy filing - Revenue up 7.1% to $1.84B, net income $59.1M, new $75M buyback, 2026 growth outlook positive.HCSG
Q4 2025 - Q3 revenue up 8.5% to $464.3M, net income $43M, aided by ERC refunds and strong segment growth.HCSG
Q3 2025 - Q3 2024 revenue and net income grew, with strong cash flow and reaffirmed guidance.HCSG
Q3 2024 - Q1 2025 saw record revenue, higher net income, and raised cash flow guidance.HCSG
Q1 2025 - Q4 revenue grew to $437.8M, but net income and margins fell; 2025 growth expected.HCSG
Q4 2024